KISS1 receptor binding
Kisspeptin-10 binds the G-protein-coupled KISS1 receptor on relevant neuroendocrine cells.
NXP / 03
Research profile
Kisspeptin
10MGKISS1-receptor agonist research peptide
Kisspeptin is a KISS1-derived signalling peptide and a potent upstream regulator of the hypothalamic reproductive axis. Kisspeptin-10 is the shortest commonly studied bioactive fragment and activates the KISS1 receptor, also known as GPR54.
Scientific context
What it does.
Controlled research uses kisspeptin to investigate gonadotropin-releasing hormone signalling, luteinising-hormone and follicle-stimulating-hormone responses, reproductive neuroendocrinology and hormone-sensitive feedback loops. Responses depend strongly on isoform, exposure pattern and model context.
Mechanism map
How the research
model works.
GnRH network activation
Receptor signalling activates upstream neurons that regulate pulsatile gonadotropin-releasing hormone output.
Downstream endocrine readout
GnRH signalling is reflected in luteinising-hormone and follicle-stimulating-hormone dynamics, providing measurable experimental endpoints.
Study design
Research pairing
options.
These are experimental design concepts—not recommendations for human use, co-administration or dosing.
CJC-1295 + IPA comparator
Provides a separate growth-hormone-axis arm for distinguishing reproductive-axis signalling from broader pituitary responses.
Use separate comparator arms; this does not establish compatibility or support co-administration.NAD+ comparator
Offers an orthogonal cellular-metabolism control where endocrine responses and energy-state measurements are collected together.
Preserve single-variable controls and predefine the primary endpoint.Unstacked control
Kisspeptin alone gives the clearest attribution of KISS1-receptor and gonadotropin responses.
Match vehicle, sampling time and exposure pattern across groups.Interpretation controls
Important
limitations.
- Kisspeptin-10, kisspeptin-54 and other isoforms are not experimentally interchangeable.
- Continuous and pulsatile exposure can produce different responses, including receptor desensitisation.
- Reproductive endocrine endpoints are highly sensitive to sex, cycle stage, age and baseline hormone status.
Evidence trail